MedTrace Logo

Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease

NCT03793491 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-01-04

No results posted yet for this study

Summary

The aim of the study is to evaluate if patients' personality could be considerate as predictive factor of quality of life after the establishment of continuous infusion of dopaminergic treatments to observe if there are predictive personality's profiles of specific therapeutic response (Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) or continuous infusion).

Conditions

  • Parkinson Disease

Interventions

OTHER

TCI scale

TCI scale : Evaluation of the patient's personality with the TCI before that the treatment by continuous infusion started.

OTHER

PDQ-39 scale

PDQ-39 scale: Comparison of life quality before and after the starting of he treatment by continuous infusion.

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Chrisitine BREFEL COURBON, PH · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-18
Primary Completion
2020-12-18
Completion
2021-06-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793491 on ClinicalTrials.gov